Drug intelligence / Profile preview

A-SUQAR

Development stage
Preclinical
Lead developer
BioXyTran
Modality
Small Molecules
Administration
Oral
01

Overview

A-SUQAR is a chewable dietary supplement developed by Bioxytran, Inc., designed to support healthy post-meal blood sugar levels. The product's active ingredient is a proprietary formulation of partially hydrolyzed guar gum (PHGG), which is based on Bioxytran's carbohydrate-based galectin platform technology. A-SUQAR functions as a nutraceutical that slows the digestion of carbohydrates in the gastrointestinal tract, thereby preventing sharp spikes in blood glucose after meals. It is intended to be taken as an oral chewable tablet before eating. Bioxytran has entered into a distribution agreement with Khoury Medical LTD for the commercialization of the product, with initial commercial shipments anticipated to begin in 2026.

Brand names
A-SUQAR
Other names
partially hydrolyzed guar gumPHGG
02

Targets

S1-NTD (SARS-CoV-2 spike S1 N-terminal domain)LGALS3 (Galectin-3)

Beyond the preview

Go deeper on A-SUQAR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A-SUQAR.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call